Literature DB >> 8893052

Analysis of human immunodeficiency virus type 1 mRNA splicing patterns during disease progression in peripheral blood mononuclear cells from infected individuals.

M J Saltarelli1, E Hadziyannis, C E Hart, J V Harrison, B K Felber, T J Spira, G N Pavlakis.   

Abstract

HIV-1 produces more than 20 mRNAs encoding the viral proteins. We have used a sensitive reverse transcriptase-polymerase chain reaction (RT-PCR) approach to determine HIV-1 transcriptional patterns during the course of viral infection in unstimulated peripheral blood mononuclear cells (PBMCs) from different patients. Several sets of PCR primers, used in parallel reactions, allowed the amplification and specific detection of almost all individual HIV-1 transcripts. We investigated the transcriptional profile in two individuals during primary acute and early chronic infection. In these individuals, HIV-1 mRNA expression was elevated at the first time points examined and declined over time. In addition, we performed a detailed study of HIV-1 expression in several individuals over a minimum of 7 years following seroconversion. We found that long-term asymptomatic individuals had undetectable or low levels of the three classes of HIV-1 transcripts (unspliced, singly spliced, and multiply spliced). Individuals who demonstrated disease progression showed either a general increase in the amount of expression of all transcripts or elevated levels of unspliced transcripts in late-stage disease. The splicing pattern in each patient was conserved over the years and differed among the different individuals. No evidence of major changes in the splicing pattern was found during disease progression within the same individual. Thus, HIV-1 transcriptional patterns are viral strain specific rather than disease stage specific. These results indicate that high-level expression of any class of HIV-1 transcripts is associated with clinical progression. Our analysis also demonstrates the importance of using more than one set of primers to evaluate HIV-1 RNA expression, since virus in patient PBMCs showed sequence heterogeneity in conserved regions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893052     DOI: 10.1089/aid.1996.12.1443

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  13 in total

1.  Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.

Authors:  S M Harrold; S J Cook; R F Cook; K E Rushlow; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Functional variability of Rev response element in HIV-1 primary isolates.

Authors:  Angsana Phuphuakrat; Prasert Auewarakul
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

3.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription.

Authors:  J A Turpin; R W Buckheit; D Derse; M Hollingshead; K Williamson; C Palamone; M C Osterling; S A Hill; L Graham; C A Schaeffer; M Bu; M Huang; W M Cholody; C J Michejda; W G Rice
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

5.  Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.

Authors:  Antonio Valentin; Margherita Rosati; Daniel J Patenaude; Angelos Hatzakis; Leondios G Kostrikis; Marios Lazanas; Kathleen M Wyvill; Robert Yarchoan; George N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

6.  Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo.

Authors:  Kara G Lassen; Justin R Bailey; Robert F Siliciano
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins.

Authors:  Angsana Phuphuakrat; Romchat Kraiwong; Chompunuch Boonarkart; Darat Lauhakirti; Tun-Hou Lee; Prasert Auewarakul
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

8.  Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy.

Authors:  S R Lewin; M Vesanen; L Kostrikis; A Hurley; M Duran; L Zhang; D D Ho; M Markowitz
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 9.  Cell-associated HIV RNA: a dynamic biomarker of viral persistence.

Authors:  Alexander O Pasternak; Vladimir V Lukashov; Ben Berkhout
Journal:  Retrovirology       Date:  2013-04-15       Impact factor: 4.602

10.  Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing.

Authors:  Karen E Ocwieja; Scott Sherrill-Mix; Rithun Mukherjee; Rebecca Custers-Allen; Patricia David; Michael Brown; Susana Wang; Darren R Link; Jeff Olson; Kevin Travers; Eric Schadt; Frederic D Bushman
Journal:  Nucleic Acids Res       Date:  2012-08-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.